COVID-19

COVID-19

US Department of Health and Human Services Announces Launch of Clinical Trials for Experimental Monoclonal Antibodies to Prevent COVID-19

Two phase 3 clinical trials testing whether experimental monoclonal antibodies can prevent infection by the SARS-CoV-2 coronavirus are now enrolling healthy adults in the United States. The trials are part of the COVID-19 Prevention Network (CoVPN), established by the National Institute of Allergy and Infectious Diseases (NIAID), and will assess